Ciclesonide (Alvesco) approved to treat asthma.
Laustsen
Gary
G
Oregon Health and Science University, La Grande, OR, USA.
D000280:Administration, Inhalation; D018926:Anti-Allergic Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D017281:Cost of Illness; D017277:Drug Approval; D006801:Humans; D008657:Metabolic Clearance Rate; D010353:Patient Education as Topic; D018579:Patient Selection; D011282:Pregnenediones / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D018926:Anti-Allergic Agents; D011282:Pregnenediones; C120481:ciclesonide